Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies.
Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.
Cellevate is an innovative biotech company that develops the next generation of cell culture systems.
Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.
Wenemea is the developer of chemotherapy-induced peripheral neuropathy designed for cancer treatment through neurological screening.
BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global Unmet Medical Needs
Plug & play autopilot for manufacturing machines with deep-tech AI ( Digital Twin, SaaS)
ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.
INERGIO is a reliable power power supply yet is a challenge to off-grid systems.
Developing patented biodegradable microencapsulation technology delivering biological protection across industries.
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.
BNovate Technologies develops automated water monitoring solutions, specializing in microbiological analysis through flow cytometry.
First AI platform on the market for real-time detection and classification of Head and Neck cancers and benign lesions.
Age Labs is a molecular diagnostics company focused on reducing the cost of developing drugs by accurately measuring your biological age.
Perciv offers AI based software solutions to unleash the hidden capabilities of radars and enable robust autonomous systems.
Magnes, has developed a disruptive real-life-monitoring solution to analyze walk patterns of patients with neurological disorders.
Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.
Smart Reporting is a digital health start-up that provides documentation software in the medical field.
Renalyse is the registered trade name of CreatSens Health S.L., a biotechnology company focusing on the development of medical platforms.
Eurostars has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eurostars's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Life Science, Therapeutics. The firm invests across 34 different industry categories.
Among tracked funding rounds, Smart Reporting received $24.5M in a Series C round. Eurostars's total known invested capital is $269.8M.
Eurostars's average investment size is $4.0M across its portfolio of 68 companies.
Recent Eurostars portfolio additions include Brenus Pharma, AlveoliX AG, Terapet, Cellevate, Polar Light Technologies. These companies were founded in 2020 or later.